ibopamine has been researched along with Disease Exacerbation in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Craig, JE; Landers, J; Ullrich, K | 2 |
Brusini, P; Salvetat, ML; Tosoni, C; Zeppieri, M | 1 |
Petrie, CJ; van Veldhuisen, DJ; Voors, AA | 1 |
Boomsma, F; Brouwer, J; Dunselman, PH; Lie, KI; Man in 't Veld, AJ; van Veldhuisen, DJ | 1 |
Bazzato, G; Bignamini, AA; Bonomini, M; Bonomini, V; Brancaccio, D; Cappelli, P; Cossu, M; De Biase, V; Docci, D; Fanciulli, E; Feletti, C; Fracasso, A; Galmozzi, C; La Manna, G; Locatelli, F; Marai, P; Mioli, V; Mosconi, G; Oldrizzi, L; Piccoli, G; Roccatello, D; Scarpioni, L; Sorba, GB; Stefoni, S; Sverzellati, E | 1 |
5 trial(s) available for ibopamine and Disease Exacerbation
Article | Year |
---|---|
Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases.
Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pupil; Tomography, Optical Coherence; Tonometry, Ocular; Visual Fields | 2015 |
Ibopamine challenge testing becomes negative following successful trabeculectomy surgery.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Glaucoma; Humans; Intraocular Pressure; Male; Prospective Studies; Tonometry, Ocular; Trabeculectomy | 2016 |
Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Young Adult | 2009 |
Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial.
Topics: Adolescent; Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Disease Progression; Dopamine Agonists; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Netherlands; Neurotransmitter Agents; Norepinephrine; Physical Exertion; Placebos; Renin; Stroke Volume; Ventricular Function, Left | 1995 |
Low-dosage ibopamine treatment in progressive renal failure: a long-term multicentre trial.
Topics: Adolescent; Aged; Creatinine; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Humans; Kidney; Kidney Failure, Chronic; Linear Models; Logistic Models; Male; Middle Aged | 1996 |
1 other study(ies) available for ibopamine and Disease Exacerbation
Article | Year |
---|---|
Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.
Topics: Aged; Deoxyepinephrine; Disease Progression; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mydriatics; Ocular Hypertension; Ophthalmoscopy; Prospective Studies; Risk Factors; Tonometry, Ocular; Visual Field Tests; Visual Fields | 2016 |